Utilizing metagenomic next-generation sequencing for diagnosis and lung microbiome probing of pediatric pneumonia through bronchoalveolar lavage fluid in pediatric intensive care unit: results from a large real-world cohort

Abstract

BackgroundMetagenomic next-generation sequencing (mNGS) is a powerful method for pathogen detection in various infections. In this study, we assessed the value of mNGS in the pathogen diagnosis and microbiome analysis of pneumonia in pediatric intensive care units (PICU) using bronchoalveolar lavage fluid (BALF) samples.MethodsA total of 104 pediatric patients with pneumonia who were admitted into PICU between June 2018 and February 2020 were retrospectively enrolled. Among them, 101 subjects who had intact clinical information were subject to parallel comparison of mNGS and conventional microbiological tests (CMTs) for pathogen detection. The performance was also evaluated and compared between BALF-mNGS and BALF-culture methods. Moreover, the diversity and structure of all 104 patients’ lung BALF microbiomes were explored using the mNGS data.ResultsCombining the findings of mNGS and CMTs, 94.06% (95/101) pneumonia cases showed evidence of causative pathogenic infections, including 79.21% (80/101) mixed and 14.85% (15/101) single infections. Regarding the pathogenesis of pneumonia in the PICU, the fungal detection rates were significantly higher in patients with immunodeficiency (55.56% vs. 25.30%, P =0.025) and comorbidities (40.30% vs. 11.76%, P=0.007). There were no significant differences in the α-diversity either between patients with CAP and HAP or between patients with and without immunodeficiency. Regarding the diagnostic performance, the detection rate of DNA-based BALF-mNGS was slightly higher than that of the BALF-culture although statistically insignificant (81.82% vs.77.92%, P=0.677) and was comparable to CMTs (81.82% vs. 89.61%, P=0.211). The overall sensitivity of DNA-based mNGS was 85.14% (95% confidence interval [CI]: 74.96%-92.34%). The detection rate of RNA-based BALF-mNGS was the same with CMTs (80.00% vs 80.00%, P>0.999) and higher than BALF-culture (80.00% vs 52.00%, P=0.045), with a sensitivity of 90.91% (95%CI: 70.84%-98.88%).ConclusionsmNGS is valuable in the etiological diagnosis of pneumonia, especially in fungal infections, and can reveal pulmonary microecological characteristics. For pneumonia patients in PICU, the mNGS should be implemented early and complementary to CMTs.

Mayaro Virus as the cause of Acute Febrile Illness in the Colombian Amazon Basin

“…Atypical viral pathogens such as Pegivirus C and bacteria such as Klebsiella pneumoniae and non-tuberculous mycobacteria have been reported in febrile and patients with respiratory illness after metagenomic sequencing analysis ( del Valle-Mendoza et al, 2017 ; Oguzie et al, 2023 ; Shen et al, 2023 ; Wei et al, 2023 ; Yang et al, 2024 ). However, further research is needed to assess its implications in disease pathogenesis, specifically in disease cases of AFI of unknown origin.…”

Metagenomic Next-Generation Sequencing-Based Fine-Needle Aspiration in Patients With Suspected Infected Pancreatic Necrosis

“…Metagenomic next-generation sequencing (mNGS) is a new technology for parallel sequencing of all microbe nucleic acids in a specimen, with a broad spectrum, including bacteria, viruses, fungi, atypical pathogens, parasites, and even new microorganisms ( 11 ). The mNGS technique has been used in multiple infectious diseases, including pneumonia, bloodstream infection, and encephalitis, demonstrating high sensitivity and timeliness, and is less affected by the use of antibiotics ( 12 , 13 ). For gastrointestinal diseases, the application of mNGS widens the pathogen spectrum compared with culture-based microbiological tests for acute intra-abdominal infections ( 14 ).…”